Table 2.
Women's characteristics | Prevalence, %* |
---|---|
Delays in days | |
Patient delay, median (IQR) | 304 (183) |
> 90 days, % (95% CI) | 90.9 (58.7–99.8) |
Healthcare delay, median (IQR) | 61 (152) |
> 90 days, % (95% CI) | 45.4 (16.7–76.6) |
Clinical characteristics | |
Histopathology | |
Squamous cell carcinoma | 72.7 |
Adenocarcinoma | 27.3 |
Cancer staging † | |
II | 45.4 |
III | 18.2 |
IV | 9.1 |
Unavailable | 18.2 |
Signs and symptoms | |
Abnormal vaginal bleeding | 90.9 |
Abnormal vaginal discharge | 63.6 |
ower abdominal or back pain | 63.6 |
Headache | 45.4 |
Fatigue | 36.4 |
Abdominal mass | 18.2 |
Syncope | 9.1 |
CC diagnosis | |
Biopsy | 63.6 |
Imaging | 18.2 |
Colposcopy | 18.2 |
Treatment | |
Surgery (hysterectomy ± partial or total removal of annexes) | 54.5 |
Surgery and chemotherapy | 18.2 |
In planning at the time of data collection | 27.3 |
Familiarity for cervical cancer | 18.2 |
Comorbidities‡ | 18.2 |
Previous use of healthcare | 18.2 |
Reasons for patient delay (N = 10) |
|
Unawareness of symptoms' seriousness | 70.0 |
Unwillingness to consult healthcare professionals | 30.0 |
Difficulty accessing healthcare | 10.0 |
Mistreated by healthcare professionals at first visit | 10.0 |
Prioritizing pressing family matters | 10.0 |
Visiting more >1 healthcare professional before diagnosis | 63.6 |
Percentages unless otherwise specified. FIGO (International Federation of Gynecologists and Obstetrics) 2018 staging classification (19). Comorbidities included self-reported major cardiovascular, respiratory, and kidney diseases, and cancer: in the present sample only two women reported having hypertension. IQR, inter-quartile range. CI, confidence intervals.